Table 1.
Patient characteristics (n = 40)
| Mean age | 65 (range: 34–93) |
|---|---|
| Gender | |
| Male | 18 (45%) |
| Female | 22 (55%) |
| Malignancy | 14 (35%) |
| Subsequent PE | 1 (2.5%) |
| Subsequent DVT | 3 (7.5%) |
| Current tobacco smoker | 20 (50%) |
| Former tobacco smoker | 1 (2.5%) |
| Oral contraceptives | 1 (2.5%) |
| HRT | 1 (2.5%) |
| Surgery within 30 Days | 7 (17.5%) |
| Anticoagulationa | 7 (17.5%) |
| Supportive therapyb | 18 (45%) |
Notes:
a
Anticoagulation included novel oral anticoagulation, Warfarin with subcutaneous heparin or subcutaneous heparin only.
b
Supportive therapies included leg elevation, pain medication, hot/cold compresses, monitoring, follow-up with primary care physician, and encouraging ambulation.
Abbreviations: DVT, deep vein thrombosis; HRT, hormone replacement therapy; PE, pulmonary embolism.